Mitchell Kapoor
Stock Analyst at HC Wainwright & Co.
(1.14)
# 3,478
Out of 4,711 analysts
250
Total ratings
28.38%
Success rate
-14.33%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Mitchell Kapoor
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ALMS Alumis | Reiterates: Buy | $26 | $8.82 | +194.78% | 3 | Dec 20, 2024 | |
| ORKA Oruka Therapeutics | Reiterates: Buy | $45 | $20.31 | +121.57% | 4 | Dec 20, 2024 | |
| SRPT Sarepta Therapeutics | Reiterates: Sell | $75 | $118.97 | -36.96% | 3 | Dec 19, 2024 | |
| HALO Halozyme Therapeutics | Reiterates: Buy | $68 | $46.96 | +44.80% | 29 | Dec 18, 2024 | |
| CARM Carisma Therapeutics | Downgrades: Neutral | n/a | $0.42 | - | 12 | Dec 16, 2024 | |
| LEGN Legend Biotech | Reiterates: Buy | $73 | $34.08 | +114.20% | 32 | Dec 10, 2024 | |
| MGX Metagenomi | Maintains: Buy | $7 → $14 | $4.05 | +245.68% | 8 | Dec 10, 2024 | |
| TCBP TC Biopharm (Holdings) | Maintains: Buy | $7 → $3 | $0.66 | +354.55% | 3 | Dec 6, 2024 | |
| RNAC Cartesian Therapeutics | Reiterates: Buy | $41 → $45 | $19.02 | +136.59% | 14 | Dec 4, 2024 | |
| RLYB Rallybio | Reiterates: Buy | $5 | $0.95 | +426.32% | 16 | Dec 3, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $55 | $22.64 | +142.93% | 13 | Nov 25, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $115 | $43.67 | +163.34% | 10 | Nov 22, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $7 → $6 | $4.00 | +50.00% | 5 | Nov 20, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $9 | $1.40 | +542.86% | 14 | Nov 19, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $44 | $17.87 | +146.22% | 11 | Nov 18, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Neutral | $5 | $2.28 | +119.30% | 4 | Nov 18, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $110 | $20.61 | +433.72% | 13 | Nov 18, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $21 → $23 | $6.28 | +266.24% | 5 | Nov 14, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Neutral | $1 | $0.61 | +63.21% | 10 | Nov 12, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $32 → $30 | $14.00 | +114.29% | 16 | Nov 11, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Neutral | n/a | $1.09 | - | 6 | Nov 11, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $15 → $14 | $5.74 | +143.90% | 3 | Nov 6, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $9 → $5 | $1.10 | +354.55% | 14 | Nov 6, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $160 → $2,440 | $0.19 | +1,311,023.05% | 2 | Sep 6, 2023 |
Alumis
Dec 20, 2024
Reiterates: Buy
Price Target: $26
Current: $8.82
Upside: +194.78%
Oruka Therapeutics
Dec 20, 2024
Reiterates: Buy
Price Target: $45
Current: $20.31
Upside: +121.57%
Sarepta Therapeutics
Dec 19, 2024
Reiterates: Sell
Price Target: $75
Current: $118.97
Upside: -36.96%
Halozyme Therapeutics
Dec 18, 2024
Reiterates: Buy
Price Target: $68
Current: $46.96
Upside: +44.80%
Carisma Therapeutics
Dec 16, 2024
Downgrades: Neutral
Price Target: n/a
Current: $0.42
Upside: -
Legend Biotech
Dec 10, 2024
Reiterates: Buy
Price Target: $73
Current: $34.08
Upside: +114.20%
Metagenomi
Dec 10, 2024
Maintains: Buy
Price Target: $7 → $14
Current: $4.05
Upside: +245.68%
TC Biopharm (Holdings)
Dec 6, 2024
Maintains: Buy
Price Target: $7 → $3
Current: $0.66
Upside: +354.55%
Cartesian Therapeutics
Dec 4, 2024
Reiterates: Buy
Price Target: $41 → $45
Current: $19.02
Upside: +136.59%
Rallybio
Dec 3, 2024
Reiterates: Buy
Price Target: $5
Current: $0.95
Upside: +426.32%
Nov 25, 2024
Reiterates: Buy
Price Target: $55
Current: $22.64
Upside: +142.93%
Nov 22, 2024
Reiterates: Buy
Price Target: $115
Current: $43.67
Upside: +163.34%
Nov 20, 2024
Maintains: Neutral
Price Target: $7 → $6
Current: $4.00
Upside: +50.00%
Nov 19, 2024
Reiterates: Buy
Price Target: $9
Current: $1.40
Upside: +542.86%
Nov 18, 2024
Reiterates: Buy
Price Target: $44
Current: $17.87
Upside: +146.22%
Nov 18, 2024
Reiterates: Neutral
Price Target: $5
Current: $2.28
Upside: +119.30%
Nov 18, 2024
Reiterates: Buy
Price Target: $110
Current: $20.61
Upside: +433.72%
Nov 14, 2024
Maintains: Buy
Price Target: $21 → $23
Current: $6.28
Upside: +266.24%
Nov 12, 2024
Reiterates: Neutral
Price Target: $1
Current: $0.61
Upside: +63.21%
Nov 11, 2024
Maintains: Buy
Price Target: $32 → $30
Current: $14.00
Upside: +114.29%
Nov 11, 2024
Reiterates: Neutral
Price Target: n/a
Current: $1.09
Upside: -
Nov 6, 2024
Maintains: Buy
Price Target: $15 → $14
Current: $5.74
Upside: +143.90%
Nov 6, 2024
Maintains: Buy
Price Target: $9 → $5
Current: $1.10
Upside: +354.55%
Sep 6, 2023
Maintains: Buy
Price Target: $160 → $2,440
Current: $0.19
Upside: +1,311,023.05%